Gerodorm - General Information:
Gerodorm is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Gerodorm is not approved for sale in the United States or Canada.
Other Brand Names containing Cinolazepam
Gerodorm - Pharmacology:
Gerodorm binds to central benzodiazepine receptors which interact allosterically with GABA receptors. This potentiates the effects of the inhibitory neurotransmitter GABA, increasing the inhibition of the ascending reticular activating system and blocking the cortical and limbic arousal that occurs following stimulation of the reticular pathways.